EXPD vs STRO
Expeditors International of Washington, Inc. (EXPD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EXPD and STRO stock pages for the full models.
Not investment advice.